Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2016.12.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Non-Vitamin K Oral Anticoagulants Versus Warfarin for Patients With Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

The Comparison of Non-Vitamin K Antagonist Oral Anticoagulants Versus Well-Managed Warfarin With a Lower INR Target of 1.5 to 2.5 in Asians Patients With Non-Valvular Atrial Fibrillation

PLoS ONE
Multidisciplinary
2019English

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Pcv31 - Anticoagulants in Older Patients With Non-Valvular Atrial Fibrillation After Intracranial Hemorrhage

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparative Effectiveness of Novel Oral Anticoagulants in UK Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease: A Matched Cohort Study

BMJ Open
Medicine
2018English

Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?

Clinical pharmacology and therapy
2019English

Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation

Jounal of arrhythmology
2020English

Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy